These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7063633)

  • 1. Adriamycin effects and the interactions of adriamycin with X irradiation on murine mammary tumors.
    Dethlefsen LA; Riley RM
    Radiat Res; 1982 Apr; 90(1):165-72. PubMed ID: 7063633
    [No Abstract]   [Full Text] [Related]  

  • 2. The interaction between adriamycin and radiation in a solid murine tumor.
    Siemann DW; Sutherland RM
    Radiat Res; 1980 Aug; 83(2):345-59. PubMed ID: 7403440
    [No Abstract]   [Full Text] [Related]  

  • 3. Mitotic delay after fractionated irradiation of autotransplants of a spontaneous mouse tumor.
    Seydel HG
    Am J Roentgenol Radium Ther Nucl Med; 1967 Aug; 100(4):938-43. PubMed ID: 4951461
    [No Abstract]   [Full Text] [Related]  

  • 4. Synergistic activity of recombinant human endostatin in combination with adriamycin: analysis of in vitro activity on endothelial cells and in vivo tumor progression in an orthotopic murine mammary carcinoma model.
    Plum SM; Hanson AD; Volker KM; Vu HA; Sim BK; Fogler WE; Fortier AH
    Clin Cancer Res; 2003 Oct; 9(12):4619-26. PubMed ID: 14555538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric analysis of adriamycin-perturbed mouse mammary tumors.
    Dethlefsen LA; Riley RM; Roti Roti JL
    J Histochem Cytochem; 1979 Jan; 27(1):463-9. PubMed ID: 374611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microvasculature of C3H/Bi mouse mammary tumors after x-irradiation.
    Hilmas DE; Gillette EL
    Radiat Res; 1975 Jan; 61(1):128-43. PubMed ID: 1110971
    [No Abstract]   [Full Text] [Related]  

  • 7. The comparative toxicity and therapeutic efficacy of adriamycin and the adriamycin-DNA complex in the chemotherapy of C3H mice with transplanted mammary adenocarcinoma.
    Brown I; Ward HW
    Cancer Lett; 1977 Mar; 2(4-5):227-32. PubMed ID: 45724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitotic delay after fractionated irradiation of C3H mammary tumor isotransplants.
    Seydel HG; Sloan K
    Radiology; 1971 Apr; 99(1):185-7. PubMed ID: 5548675
    [No Abstract]   [Full Text] [Related]  

  • 9. [Flow cytometric analysis of cell-kinetics after fractionated irradiation. II. A study on transplanted solid tumor after single dose irradiation].
    Sakai K; Fujita S; Hinata H; Sueyama H; Sato Y
    Nihon Igaku Hoshasen Gakkai Zasshi; 1985 Feb; 45(2):398-402. PubMed ID: 4011415
    [No Abstract]   [Full Text] [Related]  

  • 10. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.
    Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ
    Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions between tumor subpopulations affecting their sensitivity to the antineoplastic agents cyclophosphamide and methotrexate.
    Miller BE; Miller FR; Heppner GH
    Cancer Res; 1981 Nov; 41(11 Pt 1):4378-81. PubMed ID: 7306965
    [No Abstract]   [Full Text] [Related]  

  • 12. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model.
    Wong HL; Rauth AM; Bendayan R; Wu XY
    Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of adriamycin on the cell kinetics of 13762 rat mammary tumors and implications for therapy.
    Braunschweiger PG; Schiffer LM
    Cancer Treat Rep; 1980; 64(2-3):293-300. PubMed ID: 7407764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of hyperbaric oxygen and misonidazole in fractionated irradiation of murine tumors.
    Suit HD; Maimonis P; Michaels HB; Sedlacek R
    Radiat Res; 1981 Aug; 87(2):360-7. PubMed ID: 7268001
    [No Abstract]   [Full Text] [Related]  

  • 15. Regional differences in the growth of tumor cells injected intraperitoneally into syngeneic adult mice.
    Morrissey LW; Sidky YA; Auerbach R
    Cancer Res; 1980 Jul; 40(7):2197-201. PubMed ID: 7388788
    [No Abstract]   [Full Text] [Related]  

  • 16. Cell kinetic-directed sequential chemotherapy with cyclophosphamide and adriamycin in T1699 mammary tumors.
    Braunschweiger PG; Schiffer LM
    Cancer Res; 1980 Mar; 40(3):737-43. PubMed ID: 7471093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetically directed combination therapy with adriamycin and x-irradiation in a mammary tumor model.
    Braunschweiger PG; Schenken LL; Schiffer LM
    Int J Radiat Oncol Biol Phys; 1981 Jun; 7(6):747-53. PubMed ID: 7287535
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced adriamycin concentration in rat mammary tumors treated previously with hyperthermia.
    Wilke AV; Ausmus PL; Frazier DL
    Radiat Res; 1993 Aug; 135(2):278-80. PubMed ID: 8367599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new exploration on the creation of grafted breast cancer model for MA891 cells in TA2 mice.
    Gu JC; Yu WB; Zhang ZT; Wang Y
    Chin Med J (Engl); 2005 Nov; 118(21):1830-3. PubMed ID: 16336823
    [No Abstract]   [Full Text] [Related]  

  • 20. Distribution of adriamycin in mice under conditions of local hyperthermia which improve systemic drug therapy.
    Magin RL; Cysyk RL; Litterst CL
    Cancer Treat Rep; 1980; 64(2-3):203-10. PubMed ID: 7407753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.